Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas

NCT03532295 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Glioma
Glioblastoma

Interventions

DRUG: Epacadostat
DRUG: Bevacizumab
RADIATION: Radiation therapy
DRUG: Retifanlimab

Sponsor

Washington University School of Medicine

Collaborators

[object Object]